NasdaqGS:BIIBBiotechs
Is It Time To Reassess Biogen (BIIB) After Its 49% One Year Share Price Surge
If you are wondering whether Biogen's current share price reflects its true worth, you are not alone. Many investors are asking whether the stock still offers value after its recent moves.
The stock last closed at US$179.90, with a 1 year return of 49.3% but also shorter term moves of a 2.1% decline over 7 days, a 4.4% decline over 30 days, and a modest 1.2% gain year to date. These shifts can change how the market views both its growth potential and risk.
Recent news flow around Biogen has...